Christina Wayne, CEO of Assembly Entertainment and Founder of TelevisionSchool.com joins This Changes Things to discuss her long career in the media industry and how she took the plunge and started her own company.
Wayne has sold eighteen scripted series to major networks such as ABC, Showtime, Amazon and Cinemax. Prior to starting her own production company she helped bring "Mad Men" and "Breaking Bad" to the screen as the Senior VP of Scripted Series for AMC. She talks about what she learned when starting her own business and explains why it's important, as an owner, to be involved in every single aspect early on.
Plus, Wayne gives advice to the future women CEOs amd leaders. She says there has never been a better time to stand up for yourself and get what you deserve. She doesn't care about hearing the word "no" because she only needs one "yes" to make everything happen.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
